Article
Gene-expression profiling to predict responsiveness to immunotherapy.
Cancer gene therapy - 1 Mar 2017
Jamieson N B, Maker A V
Abstract excerpt
Recent clinical successes with immunotherapy have resulted in expanding indications for cancer therapy. To enhance antitumor immune responses, and to better choose specific strategies matched to patient and tumor characteristics, genomic-driven precision immunotherapy will be necessary. Herein, we explore the role that tumor gene-expression profiling (GEP) may have in the prediction of an immunotherapeutic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.